All articles

Semax Peptide: Benefits, Dosage, Safety, and Legality

Reading time:

13 mins

Author

Jessica Migala

Published on

Updated on

Content

Key takeaways

Ready to transform your health?

Ready to transform your health?

Get expert guidance and a personalized care plan designed around you.

Get started

Key Takeaways

Semax is a peptide developed in Russia that has been used for traumatic brain injury, stroke and other neurologic and cognitive conditions.

  • The peptide has made its way into biohacking spaces as a "brain booster," but no robust human trials support its use as a cognitive enhancer in healthy adults.

  • Semax is not FDA-approved in the United States, and it is under FDA review for possible inclusion on the 503A bulk drug substances list. It cannot currently be legally compounded, prescribed, or dispensed in the US.

  • Buying Semax from grey-market sellers comes with danger, as there are legitimate concerns about quality control, potency, impurities, and more.

  • If you are interested in peptide therapy, see a clinician for an evaluation and talk to them about your options for treatment.

Many people want an edge in performance and physical health — mental and cognitive health is no different. That's why therapies like oxytocin nasal spray have gained in popularity.

Lately, the Semax peptide has generated significant interest among biohacking communities despite it rarely being used in mainstream medicine in the United States. The problem is, this is a peptide with research almost entirely from Russia, and it has been in regulatory limbo here in the United States.

That may change in the future. Although Semax is not FDA-approved, its US regulatory status shifted in April 2026. The FDA announced on April 15, 2026 that Semax and eleven other peptides would come off the Category 2 restricted compounding list after seven calendar days, because the original nominations had been withdrawn (9). That placed Semax in line for formal review by the FDA's Pharmacy Compounding Advisory Committee (PCAC). Removal from Category 2 is not an approval, does not move a substance into Category 1, and does not authorize compounding.

We'll dive into what the Semax peptide is, what the evidence shows, how it's used and dosed, who shouldn't take it, and where things stand legally.

Key Takeaways

Semax is a peptide developed in Russia that has been used for traumatic brain injury, stroke and other neurologic and cognitive conditions.

  • The peptide has made its way into biohacking spaces as a "brain booster," but no robust human trials support its use as a cognitive enhancer in healthy adults.

  • Semax is not FDA-approved in the United States, and it is under FDA review for possible inclusion on the 503A bulk drug substances list. It cannot currently be legally compounded, prescribed, or dispensed in the US.

  • Buying Semax from grey-market sellers comes with danger, as there are legitimate concerns about quality control, potency, impurities, and more.

  • If you are interested in peptide therapy, see a clinician for an evaluation and talk to them about your options for treatment.

Many people want an edge in performance and physical health — mental and cognitive health is no different. That's why therapies like oxytocin nasal spray have gained in popularity.

Lately, the Semax peptide has generated significant interest among biohacking communities despite it rarely being used in mainstream medicine in the United States. The problem is, this is a peptide with research almost entirely from Russia, and it has been in regulatory limbo here in the United States.

That may change in the future. Although Semax is not FDA-approved, its US regulatory status shifted in April 2026. The FDA announced on April 15, 2026 that Semax and eleven other peptides would come off the Category 2 restricted compounding list after seven calendar days, because the original nominations had been withdrawn (9). That placed Semax in line for formal review by the FDA's Pharmacy Compounding Advisory Committee (PCAC). Removal from Category 2 is not an approval, does not move a substance into Category 1, and does not authorize compounding.

We'll dive into what the Semax peptide is, what the evidence shows, how it's used and dosed, who shouldn't take it, and where things stand legally.

What is Semax?

First, it's critical to note that Semax is not FDA-approved. It is also considered a drug — not a supplement.

Semax is a synthetic peptide that was developed in Russia, according to a review in the journal Pharmaceutics (1). It acts as a nootropic drug. Nootropics have been dubbed "smart drugs," and their function is to improve thinking, learning, and memory, per a research paper in Nutrients (2).

Its origin, however, traces back to the 1980s and 1990s at the Institute of Molecular Genetics where it was used for stroke and traumatic brain injury (TBI) rehabilitation in Russia.

This peptide is a hybrid molecule made up of a fragment of ACTH (adrenocorticotropic hormone) and the C-terminal tripeptide PGP (pro-gly-pro), with the cortisol-triggering portion removed, which is described as improving the molecule's stability (1). Separately, research in rats has reported a protective effect for the peptide in a model of cerebral ischemia and reperfusion, published in the International Journal of Molecular Sciences (4). Neither finding is a safety determination for human use in the United States — see the safety section below for the FDA's stated concerns.

In Russia, where it's on the list of "Vital and Essential Drugs for Medical Application," Semax is used as a medical treatment. The peptide may treat neurological problems, act as a nootropic, and has been investigated in early animal studies as a potential treatment for Alzheimer's disease, outlines a study in Acta Naturae (3). That study was conducted in transgenic mice, not people.

What is Semax?

First, it's critical to note that Semax is not FDA-approved. It is also considered a drug — not a supplement.

Semax is a synthetic peptide that was developed in Russia, according to a review in the journal Pharmaceutics (1). It acts as a nootropic drug. Nootropics have been dubbed "smart drugs," and their function is to improve thinking, learning, and memory, per a research paper in Nutrients (2).

Its origin, however, traces back to the 1980s and 1990s at the Institute of Molecular Genetics where it was used for stroke and traumatic brain injury (TBI) rehabilitation in Russia.

This peptide is a hybrid molecule made up of a fragment of ACTH (adrenocorticotropic hormone) and the C-terminal tripeptide PGP (pro-gly-pro), with the cortisol-triggering portion removed, which is described as improving the molecule's stability (1). Separately, research in rats has reported a protective effect for the peptide in a model of cerebral ischemia and reperfusion, published in the International Journal of Molecular Sciences (4). Neither finding is a safety determination for human use in the United States — see the safety section below for the FDA's stated concerns.

In Russia, where it's on the list of "Vital and Essential Drugs for Medical Application," Semax is used as a medical treatment. The peptide may treat neurological problems, act as a nootropic, and has been investigated in early animal studies as a potential treatment for Alzheimer's disease, outlines a study in Acta Naturae (3). That study was conducted in transgenic mice, not people.

Is Semax Legal in the US?

Semax was removed from the FDA Category 2 compounding list in April 2026 and went into advisory review as of July 2026. A panel of advisers to the FDA voted 8 to 5 on July 24, 2026 to recommend Semax for the 503A Bulks List, and that recommendation was tied to specific uses — cerebral ischemia, migraine, and trigeminal neuralgia — not cognitive enhancement or ADHD (10). The vote is non-binding: final inclusion would still require action by the FDA and the Secretary of Health and Human Services.

This does not mean that Semax is FDA-approved or that it was shown to be safe and effective. Currently, the peptide cannot be prescribed or dispensed by licensed US compounding pharmacies. You may see Semax sold online with a "research use only" tag. That is a seller's label, not an FDA designation or clearance, and it does not mean the product has been reviewed for safety or quality. Availability does not indicate approval.

As of July 30, 2026, the FDA’s Pharmacy Compounding Advisory Committee has recommended Semax and five other peptides for inclusion on the 503A Bulks List; final inclusion still requires action by the FDA and the Secretary of Health and Human Services.

Last reviewed: July 30, 2026. On July 30, 2026, the FDA’s Pharmacy Compounding Advisory Committee (PCAC) met at the agency’s White Oak campus to vote on whether seven peptides should be added to the 503A Bulks List. The committee recommended six of the seven peptides, including Semax, for inclusion; DSIP (delta sleep-inducing peptide) was the only one rejected. Semax’s regulatory status is actively changing; this section is reviewed and re-dated on each update.

Is Semax Legal in the US?

Semax was removed from the FDA Category 2 compounding list in April 2026 and went into advisory review as of July 2026. A panel of advisers to the FDA voted 8 to 5 on July 24, 2026 to recommend Semax for the 503A Bulks List, and that recommendation was tied to specific uses — cerebral ischemia, migraine, and trigeminal neuralgia — not cognitive enhancement or ADHD (10). The vote is non-binding: final inclusion would still require action by the FDA and the Secretary of Health and Human Services.

This does not mean that Semax is FDA-approved or that it was shown to be safe and effective. Currently, the peptide cannot be prescribed or dispensed by licensed US compounding pharmacies. You may see Semax sold online with a "research use only" tag. That is a seller's label, not an FDA designation or clearance, and it does not mean the product has been reviewed for safety or quality. Availability does not indicate approval.

As of July 30, 2026, the FDA’s Pharmacy Compounding Advisory Committee has recommended Semax and five other peptides for inclusion on the 503A Bulks List; final inclusion still requires action by the FDA and the Secretary of Health and Human Services.

Last reviewed: July 30, 2026. On July 30, 2026, the FDA’s Pharmacy Compounding Advisory Committee (PCAC) met at the agency’s White Oak campus to vote on whether seven peptides should be added to the 503A Bulks List. The committee recommended six of the seven peptides, including Semax, for inclusion; DSIP (delta sleep-inducing peptide) was the only one rejected. Semax’s regulatory status is actively changing; this section is reviewed and re-dated on each update.

How Does Semax Work?

You can think of Semax as a "cognitive optimization peptide," says integrative medicine physician Leonard Kaplan, DO, founder of OWM Integrative Wellness in Buffalo, NY. That framing reflects how the peptide is discussed in integrative and biohacking practice; it is not an established clinical use. There are two potential main uses for Semax he says:

  • In recovery from injury, specifically TBI and stroke

  • In biohacking communities to aid in focus and attention

There are two brain pathways that Semax operates in, Dr. Kaplan describes: "Semax activates BDNF. That's what makes it a nootropic." This mechanism has been described primarily in animal and laboratory research. BDNF stands for brain-derived neurotrophic factor. This protein helps neurons grow, mature, and promotes their maintenance to support proper communication between brain cells (8). "The brain is malleable. Nerves are constantly regrowing after injury," explains Dr. Kaplan, who notes that this injury can come from toxins, physical and mental stress, as well as injury.

That's why Semax has been dubbed a BDNF peptide. Dr. Kaplan says it may help maintain BDNF production, which he suggests could support recovery, repair, and reduced inflammation in the brain and nervous system. These effects have not been demonstrated in controlled human trials. Using stroke recovery as an example, Semax may be considered a treatment in Russia because of its nootropic, neuroprotective, and immune system effects, per the aforementioned Pharmaceutics paper (1).

Dopamine is the second mechanism impacted by Semax, explains Dr. Kaplan. Dopamine is a neurotransmitter that's involved in physiologic functions across the central nervous system, per Biomedicines (5). While dopamine is often associated with the reward-feedback loop and a better mood, it also has a role in motor control, motivation, and learning, notes research in Current Biology (7). Semax may encourage dopamine transmission in the brain, based on preclinical research.

How Does Semax Work?

You can think of Semax as a "cognitive optimization peptide," says integrative medicine physician Leonard Kaplan, DO, founder of OWM Integrative Wellness in Buffalo, NY. That framing reflects how the peptide is discussed in integrative and biohacking practice; it is not an established clinical use. There are two potential main uses for Semax he says:

  • In recovery from injury, specifically TBI and stroke

  • In biohacking communities to aid in focus and attention

There are two brain pathways that Semax operates in, Dr. Kaplan describes: "Semax activates BDNF. That's what makes it a nootropic." This mechanism has been described primarily in animal and laboratory research. BDNF stands for brain-derived neurotrophic factor. This protein helps neurons grow, mature, and promotes their maintenance to support proper communication between brain cells (8). "The brain is malleable. Nerves are constantly regrowing after injury," explains Dr. Kaplan, who notes that this injury can come from toxins, physical and mental stress, as well as injury.

That's why Semax has been dubbed a BDNF peptide. Dr. Kaplan says it may help maintain BDNF production, which he suggests could support recovery, repair, and reduced inflammation in the brain and nervous system. These effects have not been demonstrated in controlled human trials. Using stroke recovery as an example, Semax may be considered a treatment in Russia because of its nootropic, neuroprotective, and immune system effects, per the aforementioned Pharmaceutics paper (1).

Dopamine is the second mechanism impacted by Semax, explains Dr. Kaplan. Dopamine is a neurotransmitter that's involved in physiologic functions across the central nervous system, per Biomedicines (5). While dopamine is often associated with the reward-feedback loop and a better mood, it also has a role in motor control, motivation, and learning, notes research in Current Biology (7). Semax may encourage dopamine transmission in the brain, based on preclinical research.

What Does Semax Do? Benefits and Proposed Effects

When it comes to Semax benefits, first, a word of caution: Although there may be mechanisms identified for how Semax affects the nervous system, "having a biological mechanism does not always mean we know what happens to a patient when taking something," says Stephen Cosentino, DO, board-certified family medicine physician and president and founder of Empire Medical Training in Fort Lauderdale, FL.

While there have been in vitro, animal, and clinical studies in Russia evaluating Semax use in stroke, in neuroprotection, or as a nootropic, robust controlled trials in healthy Western adults do not yet exist.

One clinical trial published in 2018 in a Russian journal looked at 110 patients in both early and late stroke rehabilitation, finding that Semax — no matter when it was taken — was associated with higher BDNF blood levels and with faster functional recovery on the Barthel index (6). The study reported a correlation; it did not establish that Semax caused the recovery (this article is in Russian and the abstract has been translated to English). However, Semax is not a medical treatment in the US for stroke nor TBI.

Despite the fact that Semax is a pharmaceutical drug in Russia, it can be potentially harmful to conflate its use there with casual "biohacking" use here in the U.S, says Dr. Cosentino. "The current online discussion talks about Semax as if it is or could be a quick fix for cognitive and mental health issues in healthy adults when there are not enough human clinical trials to support these claims," he says. We don't have evidence that taking Semax will give you a "cognitive boost."

The studies on Semax have all come from Russia. "While this is useful data, it does not give us all the evidence we need for FDA approval here in the U.S.," adds Dr. Cosentino.

Semax Dosage and How It's Used

Because Semax is not FDA-approved and is not currently available through licensed US compounding pharmacies, this article does not provide dosing instructions or administration protocols.

Semax is typically an intranasal peptide, meaning you spray it up your nose, which may allow more direct access to your brain, says Dr. Kaplan. That differs from subcutaneous delivery, which is an injection under the skin. Since an injection is systemically absorbed, access to your central nervous system is indirect.

If you were working with a provider who prescribed Semax to you, they would determine the best route of administration depending on use, goal, as well as personal preferences (practically speaking, it's a plus not to have to give yourself an injection). That said, it is not safe to access or self-dose Semax on your own.

Intranasal vs. Subcutaneous Semax

Semax is available as a nasal spray as well as injection under the skin. Take a quick look below on how the intranasal vs subcutaneous peptide compare:


Intranasal

Subcutaneous

How it's administered

Nasal spray

Injection under the skin

Absorption

May allow more direct access to the central nervous system via the nasal mucosa

Systemic absorption; indirect CNS access

Onset

Not established in controlled human trials

Not established in controlled human trials

Practical use

More convenient; most common in research

More precise dosing possible

Primary studied use

Neuroprotection in animal and Russian clinical research

Neurological rehabilitation protocols

Semax is not FDA-approved for any use in the United States. This comparison describes routes of administration used in research and is not a treatment recommendation or dosing guidance.

Side Effects and Safety of Semax

There is a lack of data on Semax side effects and safety. The researchers in the Pharmaceutics study, who are employed at various institutions in Russia, cite that it has low toxicity potential and safety, noting that it doesn't impair the central nervous system, cardiovascular system, interact with other drugs, or cause drug dependence, addiction, or withdrawal (1).

Still, the FDA has raised specific concerns. In its briefing document for the July 2026 advisory meeting, the agency flagged the potential for immunogenicity when Semax is formulated as an injection or an intranasal spray, because of the potential for aggregation and peptide-related impurities (11). Immunogenicity means the product could trigger an immune response, which in some instances may be life-threatening. The agency also flagged a possible bleeding risk, based on nonclinical evidence of anticoagulant and antithrombotic activity. It further noted that characterization data specific to semax acetate — covering impurities, aggregates, microbial bioburden and bacterial endotoxin — were not found in the publicly available scientific literature.

Beyond Semax itself is the larger conversation about how these peptides can be accessed through grey-market suppliers. "The grey market is a dangerous place to be," says Dr. Kaplan. There are concerns not only with the purity of the raw material but also with the other ingredients used to compound the medication, which is why there are significant safety concerns about impurities, formula quality, and dose. You should not purchase Semax on your own.

Who Should Not Take Semax

Because long-term safety data about Semax is lacking, everyone should check with a health care provider before using it. This is especially important for:

  • People who are pregnant or breastfeeding

  • If you have a history of neurological conditions

  • If you are taking medications for a psychiatric or mental health condition

  • If you are taking Semax as an alternative treatment for a diagnosed condition, such as depression, anxiety, or ADHD

  • If you are sourcing from unverified suppliers; peptide vials can contain fillers, preservatives, endotoxins, or chemical residues.

Is Semax Used for ADHD?

Semax for ADHD has garnered increased interest, but it's crucial to know that no clinical trials in ADHD populations exist. The interest comes from how Semax affects dopamine, as well as anecdotal community reports. Semax use is not a substitute for evaluated ADHD treatment. Mochi does not offer Semax for ADHD or any other use. You should consult your provider if you're considering Semax for ADHD.

How to Access Peptide Therapy Safely

Semax is not an FDA-approved drug. If you are interested in peptide therapy, working with a licensed provider matters in terms of sourcing quality, medical evaluation, and continued monitoring of progress, side effects, and safety issues.

Peptides are becoming a larger part of the wellness community, but they deserve appropriate caution. "The challenge with peptides is that they really are medicines. They're not supplements, and they should not be treated like supplements, which is how the current culture treats them," says Dr. Kaplan.

Using any type of peptide warrants a thorough conversation and evaluation from a clinician. Affiliated Mochi Medical providers, accessed through Mochi, can evaluate whether peptide therapies or other medication options, like NAD+, are appropriate for you.

Non-injectable NAD+ is a dietary supplement. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

The Bottom Line

Semax is a peptide that is approved for medical use in Russia, and it may be used for stroke, TBI, or other cognitive concerns. Although the regulatory status on Semax recently changed in the United States, it is not FDA-approved and should not be accessed on one's own via the grey market. There are significant safety risks in doing so, including poor quality-control and impurity concerns. If you are interested in peptide therapy or biohacking, speak to a knowledgeable clinician to understand what treatments are available to you that get you closer to your health goals.

FAQs

Is Semax legal in the USA?

Right now, Semax is not FDA-approved as a drug in the United States. It has been removed from the FDA's Category 2 list and is under consideration for the 503A bulk substance list, which would make it eligible for compounding. It is not currently legal to compound, prescribe, or dispense in the US. Products sold online as "research use only" are labeled that way by the seller and have not been reviewed by the FDA.

What are the downsides of taking Semax?

While Semax is a drug used in Russia, that does not mean that it's been properly evaluated as safe and effective here in the United States. That means that we don't fully know all of the downsides, including safety risk and side effect profile of the peptide. In addition, accessing Semax from grey-market sources comes with quality control issues that could pose a danger to your health.

Is Semax used for ADHD?

No. Semax has not been studied for ADHD, nor is it a validated treatment for ADHD.

References

Deigin VI, Poluektova EA, Beniashvili AG, Kozin SA, Poluektov YM. Development of Peptide Biopharmaceuticals in Russia. Pharmaceutics. 2022;14(4):716. https://pmc.ncbi.nlm.nih.gov/articles/PMC9030433/

  1. Malík M, Tlustoš P. Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs. Nutrients. 2022;14(16):3367. https://pmc.ncbi.nlm.nih.gov/articles/PMC9415189/

  1. Radchenko AI, et al. The Potential of the Peptide Drug Semax and Its Derivative for Correcting Pathological Impairments in the Animal Model of Alzheimer's Disease. Acta Naturae. 2025;17(4). https://pmc.ncbi.nlm.nih.gov/articles/PMC12755871/

  1. Sudarkina OY, Filippenkov IB, Stavchansky VV, et al. Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4-7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia-Reperfusion. International Journal of Molecular Sciences. 2021;22(12):6179. https://www.mdpi.com/1422-0067/22/12/6179

  1. Franco R, Reyes-Resina I, Navarro G. Dopamine in Health and Disease: Much More Than a Neurotransmitter. Biomedicines. 2021;9(2):109. https://pmc.ncbi.nlm.nih.gov/articles/PMC7911410/

  1. Gusev EI, et al. The efficacy of semax in the treatment of patients at different stages of ischemic stroke. Zhurnal Nevrologii i Psikhiatrii. 2018. PMID 29798983. https://pubmed.ncbi.nlm.nih.gov/29798983/ [Confirm author list — article is in Russian.]

  1. Dopamine. Current Biology. 2022;32(15). https://www.sciencedirect.com/science/article/pii/S0960982222010223 [Author list to confirm.]

  1. BDNF gene. MedlinePlus Genetics. National Library of Medicine. Accessed 15 September 2026. https://medlineplus.gov/genetics/gene/bdnf/

  1. US Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. https://www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks

  1. US Food and Drug Administration. Pharmacy Compounding Advisory Committee meeting, July 23-24, 2026. https://www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026

  1. US Food and Drug Administration. FDA Briefing Document, Pharmacy Compounding Advisory Committee Meeting, Semax. July 2026. https://www.fda.gov/media/193348/download


This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting, stopping, or changing any medication or treatment plan. Semax is not approved by the FDA for any use in the United States and is not available through Mochi. Prescription medications, including peptide therapies, require a provider's evaluation and prescription. Compounded medications are not approved or evaluated by the FDA for safety, effectiveness, or quality. Individual results are not guaranteed and may vary from person to person. All professional medical services are provided by licensed physicians and clinicians affiliated with independently owned and operated professional practices.

Share this post

Jessica Migala

More articles

Read next

11 min

Finasteride for Women: Does It Work for Hair Loss?

Angela Myers

11 min

Finasteride for Women: Does It Work for Hair Loss?

Angela Myers

11 min

Finasteride for Women: Does It Work for Hair Loss?

Angela Myers

10 mins

Mochi Labs: Bloodwork That Fits Into Your Treatment

Amy Gaspardone

10 mins

Mochi Labs: Bloodwork That Fits Into Your Treatment

Amy Gaspardone

10 mins

Mochi Labs: Bloodwork That Fits Into Your Treatment

Amy Gaspardone

7 min

Ozempic Feet: What It Means and When to Call a Provider

Amy Gaspardone

7 min

Ozempic Feet: What It Means and When to Call a Provider

Amy Gaspardone

7 min

Ozempic Feet: What It Means and When to Call a Provider

Amy Gaspardone

For iOS & Android

Start with care designed for you

Start with care designed for you

What can we help you with?

What can we help you with?

Explore Treatments

Explore Treatments

Explore Treatments

Explore Treatments

Treatment

Weight Loss

Hair Loss

Skincare

Longevity

Mental Health

Menopause

Learn

Home

About us

Medications

Reviews

Blogs

FAQ

Compare

How it works

Pediatrics

Top Medications

Compounded Tirzepatide

Compounded Semaglutide

Minoxidil

NAD+

Ondansetron

Wegovy

Ozempic

Zepbound

Mounjaro

Connect

Contact us

Partner with us

Careers

Providers

Pharmacy

Follow us

All professional medical services are provided by licensed physicians and clinicians affiliated with independently owned and operated professional practices. Mochi Health Corp. provides administrative and technology services to affiliated medical practices it supports, and does not provide any professional medical services itself.

© 2026 Mochi Health

Refunds

Privacy policy

Terms & conditions

Treatment

Weight Loss

Hair Loss

Skincare

Longevity

Mental Health

Menopause

Learn

Home

About us

Medications

Reviews

Blogs

FAQ

Compare

How it works

Pediatrics

Top Medications

Compounded Tirzepatide

Compounded Semaglutide

Minoxidil

NAD+

Ondansetron

Wegovy

Ozempic

Zepbound

Mounjaro

Connect

Contact us

Partner with us

Careers

Providers

Pharmacy

Follow us

All professional medical services are provided by licensed physicians and clinicians affiliated with independently owned and operated professional practices. Mochi Health Corp. provides administrative and technology services to affiliated medical practices it supports, and does not provide any professional medical services itself.

© 2026 Mochi Health

Refunds

Privacy policy

Terms & conditions

Treatment

Weight Loss

Hair Loss

Skincare

Longevity

Mental Health

Menopause

Learn

Home

About us

Medications

Reviews

Blogs

FAQ

Compare

How it works

Pediatrics

Top Medications

Compounded Tirzepatide

Compounded Semaglutide

Minoxidil

NAD+

Ondansetron

Wegovy

Ozempic

Zepbound

Mounjaro

Connect

Contact us

Partner with us

Careers

Providers

Pharmacy

Follow us

All professional medical services are provided by licensed physicians and clinicians affiliated with independently owned and operated professional practices. Mochi Health Corp. provides administrative and technology services to affiliated medical practices it supports, and does not provide any professional medical services itself.

© 2026 Mochi Health

Refunds

Privacy policy

Terms & conditions